Nov. 12-18, 1999

U.Va. noted for high black graduation rate
Taking on hepatitis C

Health premiums to rise
Commission emphasizes primary role and breadth of public service in the University's mission
Mini-Med School

Computers marry maps, data and produce new insights

Rimel advocates renewed civic action -- nation is in need, she says
From the desk of ... Dolly Prenzel
Hot Links - Biological clocks
Biotech center launches careers, answers a need in the community
Illuminating reflections: Bibliographical devices reveal which is which
Research Computing Support Center opens
Scholarship created for E-school employees' children
Marriage benefits men by giving them positive identity, book asserts
Cavalier sports fans have many cheering options

Taking on hepatitis C

A team of researchers at the Beirne B. Carter Center for Immunology Research recently received a $660,000 grant from the Chicago-based Dr. Ralph and Marion Falk Medical Research Trust, to develop treatments and vaccines for hepatitis C and to help establish an international research center.

Hepatitis C infection, a chronic form of hepatitis caused by a virus, is spread by blood, generally through unprotected sex or needle sharing. Roughly 4 million Americans are infected, making hepatitis C the most common blood-borne infection. Although screening tests exist, most people are unaware they are infected until they are diagnosed with liver failure or liver cancer. Treatments suppress the virus in only a small number of patients.


© Copyright 1999 by the Rector and Visitors
of the University of Virginia

UVa Home Page UVa Events Calendar Top News UVa Home Page